Aurelian Therapeutics Inc entered the industry of Commercial Biotechnical Research in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact Karen Wu by calling (917) 415-5571 during business hours. You can also write to the business’ Single Location at 545 Wshngton Avenue Unit 208, Brooklyn, New York NY 11238. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Aurelian Therapeutics Inc |
Representative: | Karen Wu |
Place of Business: | 545 Wshngton Avenue Unit 208, Brooklyn, NY 11238 |
Contact Number: | (917) 415-5571 |
Type of Service: | Commercial Biotechnical Research |
SIC Number: | 8731 |
NAICS Number: | 541711 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2013 |
Income/Year: | $0 to $49.999 |
Laborers: | 1 to 4 |
Share This Company: |
Aurelian Therapeutics Inc is a company operating from Kings, New York providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Aurelian Therapeutics Inc has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Karen Wu at (917) 415-5571 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 545 Wshngton Avenue Unit 208 in Brooklyn, New York 11238 and can be engaged online through the company website at , the company Twitter , and Facebook page .